Central IRB

>> Expert Meeting

Collaboration through Innovation

Use of Central IRBs for Multi-center Clinical Trials

April 25 - 26, 2012
Hilton Washington DC/Rockville Executive Meeting Center, Rockville, MD

Project Category: Study Start-UpProject: Central IRB

CLICK HERE for a list of meeting attendees.
CLICK HERE for the meeting agenda.
CLICK HERE for the Executive Summary.


Meeting Background

The willingness of institutions to defer full local institutional review board (IRB) review and approval to a central IRB in multi-center trials continues to vary, despite a 2006 U.S. Food and Drug Administration (FDA) guidance and a more recent endorsement by the U.S. Office for Human Research Protections recommending this approach. The goal of the CTTI project is to identify potential solutions to address barriers to the adoption of central IRBs for multi-center clinical trials.


Meeting Objectives

  • Present research findings from the CTTI project entitled, Use of Central IRBs for Multi-center Clinical Trials  
  • Discuss research findings among experts present at the meeting
  • Solicit additional feedback to refine proposed solutions


Meeting Presentations


*The views and opinions expressed in this presentation are those of the individual presenter and should not be attributed to the Clinical Trials Transformation Initiative, or any organization with which the presenter is employed or affiliated.


Primary Navigation

Who We Are

Who You Are

What We Do

Briefing Room

Take Action

Contact Us


Most Visited Pages

AACT Database

CTTI Webinars

CTTI Tools

CTTI Membership

CTTI Projects


Follow Us

LinkedIn     Twitter     Facebook     Vimeo


CTTI encourages the use of all materials listed on this site in the pursuit of improving the clinical trials enterprise. Our recommendations, tools, meeting summaries, and more are available to the public for free. We do ask that you acknowledge the source whenever using or referencing CTTI materials. Read our Citation Policy here.